Search Results 801-810 of 24309 for B cell lymphomas

  1. Panobinostat and Everolimus in Treating Patients with Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma - Mayo Clinic

    Transformed lymphomas · Diffuse large B cell lymphoma · Mantle cell lymphoma · Follicular lymphoma grade III · Precursor B lymphoblastic leukemia/lymphoma ...

  2. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

    ... B-cell lymphoma (DLBCL). Tremelimumab and MEDI4736 will be tested with MEDI6469 in a set of subjects with advanced solid tumors while rituximab will be ...

  3. A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma - Mayo Clinic

    ... B) in patients with previously treated mantle cell lymphoma (MCL). Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  4. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell non-Hodgkin lymphoma (NHL), mantle cell lymphoma, transformed NHL, and follicular grade III. Not a candidate or has declined standard salvage therapy ...

  5. Clinical trials - Oncology (Medical)

    ... B-precursor Acute Lymphoblastic Leukemia (ALL). ... cell tumors (NGGCT) treated with Induction ... lymphoma (DLBCL) patients with out of specification ...

  6. Publications - Ruqin Chen, M.D., M.B. - Mayo Clinic

    ... cell lung cancer who received prior immunotherapy. Front Oncol. 2024 ... B-Cell Lymphoma. Mayo Clin Proc Innov Qual Outcomes. 2019 Dec; 3 (4):485-494 ...

  7. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma · Share ...

  8. Unleashing viruses aimed at killing cancer - Mayo Clinic News Network

    It has shown great promise by putting some B-cell lymphomas and leukemias into remission. CAR-T cells are highly targeted to tumor cells, with the goal of ...

  9. Biological therapy for cancer - Doctors & Departments - Mayo Clinic

    Related. Basal cell carcinoma · B-cell lymphoma · Burkitt lymphoma · Cancer · Carcinoid syndrome · Chronic myelogenous leukemia · Diffuse large B-cell lymphoma ...

  10. A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

    Non-CLL B-cell malignancies (Arms A, C, and D):. Histologically confirmed B-cell NHL (FL or DLBCL), transformed indolent lymphoma, and MCL: Measurable ...